At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases. We fund early-stage companies who need capital to support IND submission and clinical trials.
Company Details
- Employees
- 10
- Founded
- 2021
- Address
- 880 3rd Avenue, New York,new York 10022,united States
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://globalbioaccess.com
- HQ
- New York, New York
Global Bioaccess Fund Questions
Global Bioaccess Fund's website is http://globalbioaccess.com
Global Bioaccess Fund's LinkedIn profile is https://www.linkedin.com/company/global-bioaccess-fund
Global Bioaccess Fund has
10 employees.
View email and phone details for 10
employees at Global Bioaccess Fund.
Global Bioaccess Fund's industry is
Venture Capital and Private Equity Principals
Global Bioaccess Fund's top competitors are
Norwest,
Oncopep, Inc.,
Tellus Bioventures,
Rm Global Partners,
Avego,
Shiratronics, Inc.,
Hatch Biofund Management,
Matrix Capital Management,
Nuvig Therapeutics Inc.,
Atlas Venture.
Global Bioaccess Fund's categories are Venture Capital and Private Equity Principals
Global Bioaccess Fund's founding year is 2021
